InvestorsHub Logo
icon url

rule_rationale

05/31/14 2:36 AM

#61059 RE: ROMAD Diver #61058

Does it really show confidence by the major drug company in the developmental company's product, or are they just covering their bases?



The bases that get covered are the significant ones, so... yes, both.

Maybe more can be gleaned: a) few substances exist that do the job so the list is short and thus an explicit embodiment enabled, b) the wider scientific community is actively tracking Cellceutix compounds and NDA's that have been signed by the assignee companies allowed the scientists of those companies access to information on Kevetrin. The information the scientists received has given them cause to explicitly list Kevetrin as an example in their inventions.

Who knows for sure - just a couple of my thoughts regarding your question above.